烟台东诚药业集团股份有限公司关于控股股东部分股权质押的公告

Group 1 - The core point of the announcement is that Yantai Dongcheng Pharmaceutical Group Co., Ltd. disclosed that its controlling shareholder, Yantai Dongyi Biological Engineering Co., Ltd., has pledged part of its shares, with a total of 42,140,000 shares pledged, accounting for 33.74% of the total shares held [1][2] - As of July 25, 2025, Dongyi Biological holds 124,888,049 shares of Dongcheng Pharmaceutical, and the overall risk of share pledge is controllable, with no current risk of forced liquidation [1] - The controlling shareholder and actual controller have good credit status and repayment capability, indicating that there is no risk of forced liquidation or change in actual control [1][2] Group 2 - The company will continue to monitor the pledge situation and will disclose relevant information in a timely manner as required [1] - The announcement includes references to documents that can be reviewed, such as the details of share freezes from China Securities Depository and Clearing Co., Ltd. and transaction statements [2]